Ticker
Reporting Basis
Period
From
To
Form Type
Report Format
Update Type


UTD THERAPEUTIC   FYE=12 (December)

Annual - Income Statement - Company Specific

Fiscal period2018201720162015201420132012201120102009
Period End Date12/31/201812/31/201712/31/201612/31/201512/31/201412/31/201312/31/201212/31/201112/31/201012/31/2009
Service sales--------------------
License fees--------------------
Net product sales1,627.801,725.301,598.801,460.601,279.501,106.94906.12741.09591.70357.64
Service sales to affiliates--------------------
Other revenues------5.209.0010.049.952.091.201.24
Grant revenue--------------------
Total Revenues1,627.801,725.301,598.801,465.801,288.501,116.98916.08743.18592.90358.88
Cost of product sales198.70105.7072.7069.00125.90131.13119.3088.9067.6740.86
Cost of service sales--------------------
Research and development357.90264.60147.60245.10242.50299.35173.39180.02165.31120.37
Sales and marketing--------------------
Selling, general and administrative265.80330.10316.80452.70381.30394.01201.75156.48188.61171.89
Settlement of loss contingency0.00(210.00)0.00--------------
Total Operating Expenses------766.80749.70--494.43425.40421.59333.12
Operating Income (Loss)805.40814.901,061.70699.00538.80292.50421.65317.78171.3125.76
Interest expense13.909.003.904.7017.6018.0616.6421.3719.7112.88
Write-down of investment--------------------
Impairment of cost method investment53.5049.600.000.00------------
Gain on sale of intangible asset------350.00--0.00--------
Gain (Loss) on marketable investments--------------------
Equity loss in affiliate----------------(0.16)(0.14)
Interest income28.6010.903.50--------3.452.945.15
Other income (expense)(7.70)2.30(1.10)0.104.004.4635.66(0.75)0.770.74
Total other (expense) income, net822.40910.40537.10345.40(13.60)824.4919.03(18.67)----
Income before income tax758.90769.501,060.201,044.40525.20278.90440.67299.12155.1518.62
Current- Foreign----------2.160.660.540.850.16
Current: Federal------351.20166.40120.0383.9154.1325.0514.30
Current: State------37.0021.4020.1013.958.951.792.00
Deferred: Federal------(2.70)(3.10)(37.71)37.2611.23(1.61)(24.40)
Deferred: State------7.300.40(9.06)(0.42)(2.43)1.88(2.51)
Deferred: Foreign--------------0.64(1.29)0.17
Income tax provision (benefit)169.70351.60346.50392.80185.10104.34136.2381.8743.95(0.70)
Other Non-Current: Federal--------------7.6115.677.97
Other Non-Current: State--------------1.621.071.62
Other non-current: Foreign----------(1.06)0.18(0.42)0.54--
Income from Continuing Operations--------------217.24111.2119.32
Income from Discontinued Operations--------------0.01(5.29)0.14
Gain on disposal of discontinued operations, net of tax--------------0.62--0.00
Net Income (loss) Available to Common Shareholders589.20417.90713.70651.60340.10174.56304.44217.87105.9219.46
Income from continuing operations -EPS (Basic)--------------3.801.980.36
Discontinued operations EPS (Basic)--------------0.01(0.09)0.01
Net Earnings Per Share (Basic)13.549.5016.2914.177.063.495.843.811.890.37
Income from continuing operations -EPS (Diluted--------------3.661.870.34
Discontinued operations EPS (Diluted)--------------0.01(0.09)0.01
Net Earnings Per Share (Diluted)13.399.3115.2512.726.283.285.713.671.780.35
Weighted Average Shares Outstanding (Basic)43.5044.0043.8046.0048.2050.0852.0957.1656.1453.31
Weighted Average Shares Outstanding (Diluted)44.0044.9046.8051.2054.2053.2353.2859.4059.5256.13